{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:14:41Z","timestamp":1773850481272,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,5]]},"abstract":"<jats:p>\n                           <jats:italic toggle=\"yes\">Tripterygium wilfordii<\/jats:italic> Hook. F (TWH) has significant anti-inflammatory and immunosuppressive effects, and is widely used in the inflammatory response mediated by autoimmune diseases. However, the multi-target mechanism of TWH action in Sj\u00f6gren syndrome (SS) remains unclear. Therefore, the aim of this study was to explore the molecular mechanism of TWH in the treatment of SS using network pharmacology and molecular docking methods. TWH active components and target proteins were screened from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform. SS-related targets were obtained from the GeneCards database. After overlap, the therapeutic targets of TWH in the treatment of SS were screened. Protein-protein interaction and core target analysis were performed by STRING network platform and Cytoscape software. In addition, the affinity between TWH and the disease target was confirmed by molecular docking. Finally, the DAVID (visualization and integrated) database was used for Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis of overlapping targets. The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform database shows that TWH contains 30 active components for the treatment of SS. Protein-protein interaction and core target analysis suggested that TNF, MMP9, TGFB1, AKT1, and BCL2 were the key targets of TWH in the treatment of SS. In addition, the molecular docking method confirmed that the bioactive molecules of TWH had a high affinity with the target of SS. Enrichment analysis showed that TWH active components were involved in multiple signaling pathways. Pathways in cancer, Lipid and atherosclerosis, AGE-RAGE signaling pathway in diabetic complications is the main pathway. It is associated with a variety of biological processes such as inflammation, apoptosis, immune injury, and cancer. Based on data mining network pharmacology, and molecular docking method validation, TWH is likely to be a promising candidate for the treatment of SS drug, but still need to be further verified experiment.<\/jats:p>","DOI":"10.1097\/md.0000000000037532","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T18:03:23Z","timestamp":1712340203000},"page":"e37532","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Network pharmacology and molecular docking analysis on the mechanism of Tripterygium wilfordii Hook in the treatment of Sj\u00f6gren syndrome"],"prefix":"10.1097","volume":"103","author":[{"given":"Zelin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Laboratory, the Second Hospital of Shanxi Medical University, Taiyuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Laboratory, the Second Hospital of Shanxi Medical University, Taiyuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3656-354X","authenticated-orcid":false,"given":"Shufen","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Laboratory, the Second Hospital of Shanxi Medical University, Taiyuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41584-021-00634-x","article-title":"Current and future therapies for primary Sj\u00f6gren syndrome.","volume":"17","author":"Seror","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sj\u00f6gren\u2019s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements [published correction appears in Rheumatology (Oxford). 2017 Jul 1;56(7):1245].","volume":"54","author":"Ramos-Casals","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 118","key":"R3-20250504","first-page":"175","article-title":"Sj\u00f6gren\u2019s syndrome towards precision medicine: the challenge of harmonisation and integration of cohorts.","volume":"37","author":"Goules","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00393-006-0101-0","article-title":"Sj\u00f6gren-Syndrom. Aktuelle Aspekte aus rheumatologischer Sicht [Sj\u00f6gren\u2019s syndrome. Current aspects from a rheumatological point of view].","volume":"65","author":"Tomiak","year":"2006","journal-title":"Z Rheumatol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.23275","article-title":"Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs.","volume":"58","author":"Song","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1631\/jzus.B1900607","article-title":"Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects.","volume":"21","author":"Song","year":"2020","journal-title":"J Zhejiang Univ Sci B"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1674-6384(15)60014-4","article-title":"Network pharmacology bridges traditional application and modern development of traditional Chinese medicine.","volume":"7","author":"Chang-xiao","year":"2015","journal-title":"Chin Herbal Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.3892\/mmr.2017.7149","article-title":"Identification of the active compounds and significant pathways of yinchenhao decoction based on network pharmacology.","volume":"16","author":"Huang","year":"2017","journal-title":"Mol Med Rep"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13018-022-03194-2","article-title":"Network pharmacology and molecular docking approach to elucidate the mechanisms of Liuwei Dihuang pill in diabetic osteoporosis.","volume":"17","author":"Lu","year":"2022","journal-title":"J Orthop Surg Res"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e83922","DOI":"10.1371\/journal.pone.0083922","article-title":"Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology.","volume":"8","author":"Hsin","year":"2013","journal-title":"PLoS One"},{"key":"R12-20250504","first-page":"2211","article-title":"Sj\u00f6gren\u2019s syndrome: one year in review 2022.","volume":"40","author":"Manfr\u00e8","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s11684-018-0649-5","article-title":"Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice.","volume":"13","author":"Luo","year":"2019","journal-title":"Front Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/07853890.2021.1918345","article-title":"Multi-target mechanism of Tripterygium wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking.","volume":"53","author":"Zhang","year":"2021","journal-title":"Ann Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e34512","DOI":"10.1097\/MD.0000000000034512","article-title":"Exploring the pharmacological mechanism of Tripterygium wilfordii Hook for treatment of Behcet\u2019s disease using network pharmacology and molecular docking.","volume":"102","author":"Ye","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.47391\/JPMA.IQ-08","article-title":"The role of tumour necrosis factor alpha (TNF-ALPHA) serum level and genetic polymorphisms with cutaneous leishmania infections.","volume":"73","author":"Khamaes","year":"2023","journal-title":"J Pak Med Assoc"},{"key":"R17-20250504","first-page":"970","article-title":"Salivary cytokine profiles in primary Sj\u00f6gren\u2019s syndrome differ from those in non-Sj\u00f6gren sicca in terms of TNF-\u03b1 levels and Th-1\/Th-2 ratios.","volume":"29","author":"Kang","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"201049","DOI":"10.1016\/j.humgen.2022.201049","article-title":"Tissue inhibitor of metalloproteinase-1 (TIMP-1) serum level and genetic polymorphisms associated with cutaneous leishmania infections.","volume":"33","author":"Khamaes","year":"2022","journal-title":"Human Gene"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"14552","DOI":"10.1038\/s41598-022-18576-z","article-title":"Regulation of MMP9 transcription by ETS1 in immortalized salivary gland epithelial cells of patients with salivary hypofunction and primary Sj\u00f6gren\u2019s syndrome.","volume":"12","author":"Noll","year":"2022","journal-title":"Sci Rep"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/1529-0131(200012)43:12<2807::AID-ANR22>3.0.CO;2-M","article-title":"Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome.","volume":"43","author":"P\u00e9rez","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.29219\/fnr.v65.7526","article-title":"The mechanism and candidate compounds of aged citrus peel (chenpi) preventing chronic obstructive pulmonary disease and its progression to lung cancer.","volume":"65","author":"Zhou","year":"2021","journal-title":"Food Nutr Res"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/COH.0b013e328335c2f6","article-title":"Th17 cytokines in mucosal immunity and inflammation.","volume":"5","author":"Guglani","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4049\/jimmunol.1602144","article-title":"IFN-\u03b3-expressing Th17 cells are required for development of severe ocular surface autoimmunity.","volume":"199","author":"Chen","year":"2017","journal-title":"J Immunol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaut.2017.11.003","article-title":"Th17 cells in primary Sj\u00f6gren\u2019s syndrome: pathogenicity and plasticity.","volume":"87","author":"Verstappen","year":"2018","journal-title":"J Autoimmun"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41374-020-0373-z","article-title":"TGF\u03b21-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial-mesenchymal transition in Sj\u00f6gren\u2019s syndrome.","volume":"100","author":"Sisto","year":"2020","journal-title":"Lab Invest"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.autrev.2014.08.022","article-title":"Unmasking the pathogenic role of IL-17 axis in primary Sj\u00f6gren\u2019s syndrome: a new era for therapeutic targeting?","volume":"13","author":"Alunno","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"104977","DOI":"10.1016\/j.jprot.2023.104977","article-title":"Proteomics profiling and lysine malonylation analysis in primary Sjogren\u2019s syndrome.","volume":"287","author":"Liao","year":"2023","journal-title":"J Proteomics"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"8048170","DOI":"10.1155\/2016\/8048170","article-title":"Triptolide inhibits osteoclast differentiation and bone resorption in vitro via enhancing the production of IL-10 and TGF-\u03b21 by regulatory T cells.","volume":"2016","author":"Xu","year":"2016","journal-title":"Mediators Inflamm"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11626-019-00409-5","article-title":"MiR-let-7d-3p regulates IL-17 expression through targeting AKT1\/mTOR signaling in CD4 T cells.","volume":"56","author":"Wang","year":"2020","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/1871530321666210809155147","article-title":"Association between increased Bcl-2, Fas and FasL levels and inflammation extent in labial salivary glands during primary Sj\u00f6gren\u2019s syndrome.","volume":"22","author":"Benchabane","year":"2022","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"103084","DOI":"10.1016\/j.autrev.2022.103084","article-title":"Primary Sj\u00f6gren\u2019s syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis.","volume":"21","author":"Zhong","year":"2022","journal-title":"Autoimmun Rev"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3389\/fimmu.2019.00817","article-title":"Subclinical atherosclerosis in primary Sj\u00f6gren\u2019s syndrome: does inflammation matter?","volume":"10","author":"Bartoloni","year":"2019","journal-title":"Front Immunol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e36144","DOI":"10.1097\/MD.0000000000036144","article-title":"Network pharmacology identifies the inhibitory effect of Yiqiyangyinquyu prescription on salivary gland inflammation in Sj\u00f6gren\u2019s syndrome.","volume":"102","author":"Hong","year":"2023","journal-title":"Medicine (Baltim)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:08:02Z","timestamp":1746331682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":33,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037532","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]}}}